| Does the ‘hikikomori’ syndrome of social withdrawal exist outside Japan? A preliminary international investigation TA Kato, M Tateno, N Shinfuku, D Fujisawa, AR Teo, N Sartorius, ... Social psychiatry and psychiatric epidemiology 47 (7), 1061-1075, 2012 | 339 | 2012 |
| Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: a systematic review and meta-analysis of clinical trials and biological studies JPC Chang, KP Su, V Mondelli, CM Pariante Neuropsychopharmacology 43 (3), 534, 2018 | 241 | 2018 |
| Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial KP Su, HC Lai, HT Yang, WP Su, CY Peng, JPC Chang, HC Chang, ... Biological psychiatry 76 (7), 559-566, 2014 | 233 | 2014 |
| Maternal parenting styles and mother–child relationship among adolescents with and without persistent attention-deficit/hyperactivity disorder SSF Gau, JPC Chang Research in developmental disabilities 34 (5), 1581-1594, 2013 | 185 | 2013 |
| Safety and tolerability of prescription omega-3 fatty acids: a systematic review and meta-analysis of randomized controlled trials CH Chang, PT Tseng, NY Chen, PC Lin, PY Lin, JPC Chang, FY Kuo, ... Prostaglandins, Leukotrienes and Essential Fatty Acids 129, 1-12, 2018 | 101 | 2018 |
| High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA … JPC Chang, KP Su, V Mondelli, SK Satyanarayanan, HT Yang, YJ Chiang, ... Translational Psychiatry 9 (1), 1-9, 2019 | 89 | 2019 |
| Attention deficit hyperactivity disorder and N-methyl-D-aspartate (NMDA) dysregulation J Pei-Chen Chang, HY Lane, G E Tsai Current pharmaceutical design 20 (32), 5180-5185, 2014 | 71 | 2014 |
| Cortisol, Inflammatory Biomarkers and Neurotrophins in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) in Taiwan JPC Chang, V Mondelli, SK Satyanarayanan, YJ Chiang, HT Chen, KP Su, ... Brain, Behavior, and Immunity, 2020 | 69 | 2020 |
| The Now and Future of ChatGPT and GPT in Psychiatry SW Cheng, CW Chang, WJ Chang, HW Wang, CS Liang, T Kishimoto, ... Psychiatry and Clinical Neurosciences, 2023 | 67 | 2023 |
| Introducing the concept of modern depression in Japan; an international case vignette survey TA Kato, N Shinfuku, D Fujisawa, M Tateno, T Ishida, T Akiyama, ... Journal of Affective Disorders 135 (1-3), 66-76, 2011 | 63 | 2011 |
| Interferon-alpha-induced depression: Comparisons between early-and late-onset subgroups and with patients with major depressive disorder KP Su, HC Lai, CY Peng, WP Su, JPC Chang, CM Pariante Brain, behavior, and immunity, 2019 | 53 | 2019 |
| Melatonergic agonist regulates circadian clock genes and peripheral inflammatory and neuroplasticity markers in patients with depression and anxiety SK Satyanarayanan, YC Chien, JPC Chang, SY Huang, TW Guu, H Su, ... Brain, behavior, and immunity, 2019 | 53 | 2019 |
| Polyunsaturated fatty acids and inflammatory markers in major depressive episodes during pregnancy JPC Chang, CY Lin, PY Lin, YH Shih, TH Chiu, M Ho, HT Yang, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 80, 273-278, 2018 | 51 | 2018 |
| Nutritional Neuroscience as Mainstream of Psychiatry: The Evidence-Based Treatment Guidelines for Using Omega-3 Fatty Acids as a New Treatment for Psychiatric Disorders in … JPC Chang, KP Su | 49* | |
| Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis JPC Chang, KP Su, V Mondelli, CM Pariante Translational psychiatry 11 (1), 1-10, 2021 | 47 | 2021 |
| Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder–Results from a randomized controlled trial JPC Chang, SS Chang, HT Yang, HT Chen, YC Chien, B Yang, H Su, ... Brain, behavior, and immunity, 2019 | 46 | 2019 |
| Omega-3 fatty acids in the psychological and physiological resilience against COVID-19 JPC Chang, CM Pariante, KP Su Prostaglandins, Leukotrienes and Essential Fatty Acids 161, 102177, 2020 | 40 | 2020 |
| Melatonergic agents in the prevention of delirium: A network meta-analysis of randomized controlled trials CP Yang, PT Tseng, JPC Chang, H Su, SK Satyanarayanan, KP Su Sleep Medicine Reviews, 101235, 2019 | 38 | 2019 |
| Clinical Efficacy and Biological Regulations of ω–3 PUFA-Derived Endocannabinoids in Major Depressive Disorder B Yang, L Lin, RP Bazinet, YC Chien, JPC Chang, SK Satyanarayanan, ... Psychotherapy and psychosomatics 88 (4), 215-224, 2019 | 38 | 2019 |
| Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression JPC Chang, SS Chang, HT Yang, M Palani, CP Chen, KP Su Brain, behavior, and immunity 44, 28-31, 2015 | 37 | 2015 |
